EO Care 360° · Clinician View

From Epic

Epic

Diagnosis: Breast IDC, ER+/PR+/HER2−, bone mets (L2, R ilium)
Treatment: Dose-dense AC q2w → tamoxifen · cycle 1 of 4
ECOG: 1
Worst pain: 6/10, getting worse
Pain meds: Naproxen × 3 wks, partial relief · opioid-naive
Labs: Hgb 10.8 ↓ · eGFR 92 · ALP 184 ↑
Other: T2DM · HTN · depression on file · NKDA

Full record

Diagnosis & treatment

Pre-cycle labs

Home medications

Pain & opioid safety

What Sarah Told Us

Her intake before the visit, then her check-ins

Patient-reported

Intake12 answers · before the visit

Most worried about pain, then fatigue
Wants to avoid feeling high, constipation, weight gain
Open to CBD and THC · no to acupuncture and massage
Pain getting worse; no other pain medicine
Ondansetron took it before and it helped

"I'd rather try that than a narcotic."

All 12 answers

patient-reported all responses collected in the patient app before the visit · opioid risk screen = Opioid Risk Tool (stand-in for the sourced instrument) · "intoxication" → EO cannabinoid model only

FeedbackNo check-ins yet

Likely Symptoms · Next 30 Days

From her chart and her answers

Build the plan first.

Confirm what goes into Epic and into Sarah's app.

How Closely We'll Watch

Escalation risk, per symptom: how likely it is to need a person. It sets monitoring and never changes the plan.

Full escalation scoring and monitoring plan

After You Sign

Your preferences as attending clinician: what M may adjust on its own from Sarah's daily check-ins

Orders

0/0 signed

Sarah's dashboard opens once her plan is confirmed and sent.

Preferences for Sarah

What M may change on its own after you sign. Set per patient; you can change it any time.

Auto-approve changes to

🧘

Integrative therapy changes Structured physical activity, Mind-body intervention, Cognitive behavioral therapy for insomnia

💊

OTC medication changes Non-opioid analgesic, Bowel regimen, Magnesium glycinate · in-ladder dose steps (sennosides / PEG / bisacodyl) are the Day-7 case

🥛

Supplement changes Omega-3 fatty acids, B-complex vitamins

🌿

Cannabinoid changes Cannabinoid therapy · product & dose set by the EO cannabinoid clinician; opt in only if the model may enact their dose steps

Prescriptions and controlled substances always come to you. Any holding flag or red-flag alert sends a change back to you. M never changes the first plan; that one is always yours to sign.

Risk inputs, dose ceilings and patient caps

⚠ Prescription and controlled classes always require clinician approval · the opioid, benzodiazepine, olanzapine and the prescription antiemetics go to Dr. Reyes every time. Any change that raises a holding flag, a red-flag alert or a severity alert in the window routes to clinician review regardless of these settings. Defaults are the model's autonomy ceiling (feedback.titrateDose.autonomousCategories). Three things decide whether a change happens without review: the clinician's category opt-in above, the patient's autonomy level (set from risk, one dropdown to override), and the safety rules that always apply per class · the engine can only ever tighten, never widen.